Array BioPharma   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Boulder CO United States (1998)
Status: Acquired by Pfizer (2019)

Organization Overview

First Clinical Trial
2004
NCT00085787
First Marketed Drug
2018
binimetinib (mektovi)
First NDA Approval
2018
binimetinib (mektovi)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Array BioPharma | Array BioPharma, Inc | Array BioPharma, Inc. | ARRAY BIOPHARMA INC